Community/Retail

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions speaks about the possible change of the pathway program due to alternative payment models, such as the Oncology Care Model.

Smith Drug Company has announced that Matthew Pike has been named to the newly-created position of Associate Vice President of Strategy, Industry Relations.

Although the FDA is not bound by the recommendation of the committee, their advice is taken into consideration.

Officials with the FDA have announced the approval of glecaprevir and pibrentasvir (Mavyret, AbbVie Inc) for hepatitis C.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

HIV continues to be a global problem, and researchers from Brazil have joined the growing chorus of voices in emphasizing that pharmacist involvement in care for patients with HIV improves outcomes.

What is the importance and prevalence of treat-to-target?

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions, talks about the role pharmacists can play in potential education for patients outside of the oncology clinic.

Allscripts has announced a definitive agreement to acquire McKesson Corporation’s hospital and health system IT business, Enterprise Information Solutions, for $185 million in cash.

The efficacy and safety of ibrutinib for the treatment of cGVHD were studied in a single-arm trial of 42 patients with cGVHD whose symptoms persisted despite standard treatment with corticosteroids.

Pharmacists can play a crucial role in promoting the flu vaccine to these patients by recognizing the characteristics of those who do not seek vaccinations.

Pharmacists play an important role in counseling patients on biologics.

A recently-released video from the CDC provides a great way to discuss vaccines with parents.

Pharmacists' increasing role in providing patient education and contact.

Officials with the FDA have approved enasidenib (Idhifa, Celgene Corporation) to treat adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation, isocitrate dehydrogenase-2 (IDH2), according to a FDA press release.

Is it time to change the type 2 diabetes treatment paradigm?

Offspring of pollutant-exposed ancestors also showed elevated levels of interleukin proteins that are involved in regulating the immune system, which are a marker of asthma risk.

Charlie Le Bon, the Director of Pharmacy Ownership for AmerisourceBergen, discusses recent changs in the pharmacy landscape.

The next time you see a bucket of chicken, I hope you reminds you my absolute favorite pneumonic device and how you can begin to work towards any goal you set out to achieve. Fortunately, this acronym is easy to remember and seen all over the world with signs of a global food franchise: Kentucky Fried Chicken, otherwise known as KFC.

The FDA has issued a safety alert after receiving serious adverse events reports regarding intravitreal (eye) injections of a medication containing triamcinolone and moxifloxacin.

Cardinal Health has completed the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency business for $6.1 billion.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

A vast buyer network can assist with purchasing community pharmacies.

Tennessee drug company Crown Laboratories Inc. has agreed to cease the manufacturing and distribution of unapproved and misbranded dermatologic creams and lotions.

A Mississippi pharmacist in charge of a compounding pharmacy pleaded guilty to his role in a $192 million compounded medication scheme, according to the Department of Justice (DOJ).

Pharmacists continue to rank among best-paying professions, but competition in the job market is high.

An FDA panel voted against recommending Intellipharmaceutics’ Rexista abuse-deterrent oxycodone hydrochloride extended release tablets, according to a company press release.